Dawn Moore Jefferson, PharmD
Articles by Dawn Moore Jefferson, PharmD

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)
ByE. Thomas Carey, PharmD,Ryan A. Forrey, MS,Douglas Haughs, BS,Dawn Moore Jefferson, PharmD,James A. Jorgenson, RPh, MS,Derek M. McMichael, PharmD,John M. Mulvaney, MHA,Susan M. Spivey, Phar The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.

Utility of the PhaSeal Closed System Drug Transfer Device
ByDerek M. McMichael, PharmD,Dawn Moore Jefferson, PharmD,E. Thomas Carey, PharmD,Ryan A. Forrey, PharmD, MS,Susan M. Spivey, PharmD, DDS,John M. Mulvaney, MHA,James A. Jorgenson, RPh, MS,R. The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.